EMEA (Europe, Middle East and Africa) Antivenom Market 2017 Forecast to 2022
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Scope of the Report:
This report focuses on the Antivenom in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Merck & Co., Inc.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
Polyvalent antivenom
Monovalent antivenom
Market Segment by Applications, can be divided into
Retail Pharmacies
Hospitals
Others
There are 13 Chapters to deeply display the EMEA Antivenom market.
Chapter 1, to describe Antivenom Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antivenom, with sales, revenue, and price of Antivenom, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Antivenom, for each region, from 2012 to 2017;
Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;
Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 10, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 11, 12 and 13, to describe Antivenom research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Scope of the Report:
This report focuses on the Antivenom in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Merck & Co., Inc.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
Polyvalent antivenom
Monovalent antivenom
Market Segment by Applications, can be divided into
Retail Pharmacies
Hospitals
Others
There are 13 Chapters to deeply display the EMEA Antivenom market.
Chapter 1, to describe Antivenom Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antivenom, with sales, revenue, and price of Antivenom, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Antivenom, for each region, from 2012 to 2017;
Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;
Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 10, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 11, 12 and 13, to describe Antivenom research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
